Osmany Guirola Cruz

Citata da

	Tutte	Dal 2019
Citazioni	657	413
Indice H	16	13
i10-index	22	18

2010201120122013201420152016201720182019202020212022202320248 14 11 8 23 38 47 38 40 54 68 60 53 90 86

Accesso pubblico

Visualizza tutto

4 articoli

0 articoli

Disponibili

Non disponibili

In base ai mandati di finanziamento

Coautori

Luis Javier González LópezCenter for Genetic Engineering and Biotechnology, Mass Spectrometry Laboratory. Systems Havana, CubaEmail verificata su cigb.edu.cu
Yassel Ramos GómezCenter for Genetic Engineering and BiotechnologyEmail verificata su cigb.edu.cu
vladimir besadacentro de ingeniería genética y biotecnologíaEmail verificata su cigb.edu.cu
Yasset Perez-RiverolTeam Coordinator, Proteomics Resources, EMBL-EBI, UKEmail verificata su ebi.ac.uk
Alexis YeroHarvard Medical School/Massachusetts General HospitalEmail verificata su mgh.harvard.edu
Gleysin CabreraCenter for Genetic Engineering and BiotechnologyEmail verificata su cigb.edu.cu
Teresa Nuñez de Villavicencio DiazWestern UniversityEmail verificata su uwo.ca
Alejandro MartinStaff researcher, Center for Genetic Engineering and Biotechnology, CubaEmail verificata su cigb.edu.cu
Julio Raúl Fernández MassóCentro de Ingeniería Genética y BiotecnologíaEmail verificata su cigb.edu.cu
Aniel Sanchez PuenteSenior ResearcherEmail verificata su northwestern.edu
Bruno DomonEmail verificata su crp-sante.lu
Gertrudis RojasSenior researcher and Head of the Protein Engineering Department, Center of Molecular ImmunologyEmail verificata su cim.sld.cu
Roberto Vera Alvarez, PhDNational Center for Biotechnology InformationEmail verificata su ncbi.nlm.nih.gov
Gerardo GuillenBiomedical Research Director, Center for Genética Engineering and Biotechnology, Havana, CubaaEmail verificata su cigb.edu.cu
Lennart MartensSenior Full Professor of Systems Biology, Ghent University and VIB, Ghent, BelgiumEmail verificata su UGent.be
Henning HermjakobHead of Molecular Systems, European Bioinformatics Institute (EMBL-EBI)Email verificata su ebi.ac.uk
Juergen CoxMax Planck Institute of BiochemistryEmail verificata su biochem.mpg.de
Oliver KohlbacherProfessor for Applied Bioinformatics, University of TübingenEmail verificata su uni-tuebingen.de
Pedro A ValienteDonnelly Center for Cellular and Biomolecular Research, Faculty of Medicine, University of TorontoEmail verificata su utoronto.ca
Jeovanis Gil ValdésDepartment of Translational Medicine, Lund UniversityEmail verificata su med.lu.se

Segui

Osmany Guirola Cruz

Center for Genetic Engineering and Biotechnology

Email verificata su cigb.edu.cu

Computational Biology Drug Design Computational Chemistry Computer-aided drug design structure-based drug design


Titolo Ordina per citazioni Ordina per anno Ordina per titolo	Citata da Citata da	Anno
Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody R Alonso, V Huerta, J de Leon, P Piedra, Y Puchades, O Guirola, ... Hybridoma 27 (4), 291-301, 2008	96	2008
A comparative molecular dynamics study of thermophilic and mesophilic β-fructosidase enzymes Y Mazola, O Guirola, S Palomares, G Chinea, C Menéndez, L Hernández, ... Journal of Molecular Modeling 21, 1-11, 2015	94	2015
Functional and mass spectrometric evaluation of an anti-tick antigen based on the P0 peptide conjugated to Bm86 protein A Rodríguez Mallón, L Javier González, PE Encinosa Guzmán, ... Pathogens 9 (6), 513, 2020	36	2020
CIGB-300 anticancer peptide regulates the protein kinase CK2-dependent phosphoproteome Y Perera, Y Ramos, G Padrón, E Caballero, O Guirola, LG Caligiuri, ... Molecular and cellular biochemistry 470, 63-75, 2020	34	2020
Synthesis, LC-MS/MS analysis, and biological evaluation of two vaccine candidates against ticks based on the antigenic P0 peptide from R. sanguineus linked to the p64K … LJ González, PE Encinosa Guzmán, W Machado, S Pousa, A Leyva, ... Analytical and Bioanalytical Chemistry 413, 5885-5900, 2021	28	2021
Chemical compounds having antiviral activity against dengue virus and other flaviviruses YM Reyes, GC Santiago, OG Cruz, RV Alvarez, VH Galindo, NF Salazar, ... US Patent 8,722,742, 2014	28	2014
Pharmacophore model of immunocheckpoint protein PD-L1 by cosolvent molecular dynamics simulations C Mejías, O Guirola Journal of Molecular Graphics and Modelling 91, 105-111, 2019	25	2019
Methods and Proteins for the Prophylactic and/or Therapeutic Treatment of Four Serotypes of Dengue Virus and Other Flaviviruses GC Santiago, VH Galindo, AMM Dunn, JVG Cowley, NF Salazar, OG Cruz, ... US Patent App. 12/094,503, 2009	25	2009
Investigacion social: teoria, metodo y creatividad MC Souza, S Ferreira, O Cruz, R Gomes Argentina: Lugar Editorial 13, 2003	25	2003
Investigación social M De Souza, S Ferreira, O Cruz, R Gómez Teoría, método y creatividad. Buenos Aires: Lugar, 2003	25	2003
Novel interactions of domain III from the envelope glycoprotein of dengue 2 virus with human plasma proteins V Huerta, Y Ramos, A Yero, D Pupo, D Martín, P Toledo, N Fleitas, ... Journal of proteomics 131, 205-213, 2016	23	2016
Receptor-activated human α₂-macroglobulin interacts with the envelope protein of dengue virus and protects virions from temperature-induced inactivation through … V Huerta, P Toledo, N Fleitas, A Martín, D Pupo, A Yero, M Sarría, ... Journal of General Virology 95 (12), 2668-2676, 2014	22	2014
Comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells TN de Villavicencio-Díaz, YR Gómez, BO Argüelles, JRF Masso, ... Journal of proteomics 126, 163-171, 2015	21	2015
Bioinformatics tools for the functional interpretation of quantitative proteomics results T Nunez Villavicencio-Diaz, A Rodríguez-Ulloa, O Guirola-Cruz, ... Current topics in medicinal chemistry 14 (3), 435-449, 2014	21	2014
Computational proteomics pitfalls and challenges: HavanaBioinfo 2012 workshop report Y Perez-Riverol, H Hermjakob, O Kohlbacher, L Martens, D Creasy, J Cox, ... Journal of proteomics 87, 134-138, 2013	21	2013
A deeper mining on the protein composition of VA-MENGOC-BC®: An OMV-based vaccine against N. meningitidis serogroup B and C Y Masforrol, J Gil, D Garcia, J Noda, Y Ramos, L Betancourt, O Guirola, ... Human Vaccines & Immunotherapeutics 13 (11), 2548-2560, 2017	19	2017
Predicting CK2 beta-dependent substrates using linear patterns TN de Villavicencio-Díaz, Y Mazola, YP Negrín, YC García, OG Cruz, ... Biochemistry and biophysics reports 4, 20-27, 2015	16	2015
Method to block the infection by flaviviruses, molecules and uses VH Galindo, GC Santiago, NF Salazar, AMM Dunn, MS Nunez, OG Cruz, ... US Patent 8,420,311, 2013	12	2013
Isolation of a novel neutralizing antibody fragment against human vascular endothelial growth factor from a phage-displayed human antibody repertoire using an epitope … H Lamdan, M Ayala, G Rojas, Y Munoz, Y Morera, O Guirola, G Chinea, ... Journal of biotechnology 151 (2), 166-174, 2011	12	2011
Novel insights into the molecular mechanisms involved in the neuroprotective effects of C-Phycocyanin against brain ischemia in rats J Marín-Prida, JL Liberato, A Llópiz-Arzuaga, K Stringhetta-Padovani, ... Current Pharmaceutical Design 28 (14), 1187-1197, 2022	11	2022

Il sistema al momento non può eseguire l'operazione. Riprova più tardi.

Articoli 1–20

Citazioni per anno

Citazioni duplicate

Citazioni unite

Aggiungi coautoriCoautori

Segui

Citata da

Coautori